(Q35821964)

10 August 2017

1 reference

title

Review article: targeted screening for hereditary haemochromatosis in high-risk groups (English)

1 reference

10 August 2017

1 reference

S DuBois

1

1 reference

10 August 2017

K V Kowdley

series ordinal

2

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 July 2004

1 reference

Alimentary Pharmacology & Therapeutics

10 August 2017

published in

1 reference

10 August 2017

volume

20

1 reference

10 August 2017

issue

1

1 reference

10 August 2017

page(s)

1-14

1 reference

EASL International Consensus Conference on Haemochromatosis

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02024.X

The effect of HFE genotypes on measurements of iron overload in patients attending a health appraisal clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02024.X

Population-based screening for hemochromatosis using phenotypic and DNA testing among employees of health maintenance organizations in Springfield, Missouri

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02024.X

A population-based study of the clinical expression of the hemochromatosis gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02024.X

Screening for hemochromatosis and iron deficiency in employees and primary care patients in Western Germany.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02024.X

Hemochromatosis screening in asymptomatic ambulatory men 30 years of age and older

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02024.X

A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02024.X

Hemochromatosis-associated mortality in the United States from 1979 to 1992: an analysis of Multiple-Cause Mortality Data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02024.X

Population screening for hemochromatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02024.X

Cost-effectiveness of screening for hereditary hemochromatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02024.X

The cost-effectiveness of cervical screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02024.X

Prevalence of hereditary hemochromatosis in 16031 primary care patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02024.X

Evaluation of a workplace hemochromatosis screening program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02024.X

Nonexpressing homozygotes for C282Y hemochromatosis: minority or majority of cases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02024.X

Penetrance of 845G--> A (C282Y) HFE hereditary haemochromatosis mutation in the USA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02024.X

Hemochromatosis mutations in the general population: iron overload progression rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02024.X

Hemochromatosis and Iron Overload Screening (HEIRS) study design for an evaluation of 100,000 primary care-based adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02024.X

Testing for haemochromatosis in the diabetic clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02024.X

Liver iron stores in patients with non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02024.X

Role of C282Y mutation in haemochromatosis gene in development of type 2 diabetes in healthy men: prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02024.X

HFE mutations in an inflammatory arthritis population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02024.X

Screening for genetic haemochromatosis in a rheumatology clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02024.X

Haemochromatosis gene mutations in idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02024.X

Abnormal liver enzyme levels. Clinical evaluation in asymptomatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02024.X

Screening for genetic haemochromatosis in blood samples with raised alanine aminotransferase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02024.X

Testing for haemochromatosis in a liver clinic population: relationship between ethnic origin, HFE gene mutations, liver histology and serum iron markers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02024.X

HFE genotype in patients with hemochromatosis and other liver diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02024.X

The role of iron and haemochromatosis gene mutations in the progression of liver disease in chronic hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02024.X

Hemochromatosis gene mutations in chronic hepatitis C patients with and without liver siderosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02024.X

Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02024.X

Hepatic iron overload in patients with chronic viral hepatitis: role of HFE gene mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02024.X

Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in North America

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02024.X

Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02024.X

HFE gene mutations in alcoholic and virus-related cirrhotic patients with hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02024.X

Diagnosis and management of hemochromatosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02024.X

Screening for hemochromatosis in children of homozygotes: prevalence and cost-effectiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02024.X

Liver iron accumulation in patients with chronic active hepatitis C: prevalence and role of hemochromatosis gene mutations and relationship with hepatic histological lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02024.X

10.1111/J.1365-2036.2004.02024.X

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference